ATE323166T1 - Fragmente der intron a von citomegalovirus - Google Patents

Fragmente der intron a von citomegalovirus

Info

Publication number
ATE323166T1
ATE323166T1 AT01979785T AT01979785T ATE323166T1 AT E323166 T1 ATE323166 T1 AT E323166T1 AT 01979785 T AT01979785 T AT 01979785T AT 01979785 T AT01979785 T AT 01979785T AT E323166 T1 ATE323166 T1 AT E323166T1
Authority
AT
Austria
Prior art keywords
fragments
intron
citomegalovirus
cytomegalovirus
cmv
Prior art date
Application number
AT01979785T
Other languages
English (en)
Inventor
Kent Thudium
Mark Selby
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE323166T1 publication Critical patent/ATE323166T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C12N2840/445—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor for trans-splicing, e.g. polypyrimidine tract, branch point splicing
AT01979785T 2000-10-13 2001-10-12 Fragmente der intron a von citomegalovirus ATE323166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24050200P 2000-10-13 2000-10-13

Publications (1)

Publication Number Publication Date
ATE323166T1 true ATE323166T1 (de) 2006-04-15

Family

ID=22906778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979785T ATE323166T1 (de) 2000-10-13 2001-10-12 Fragmente der intron a von citomegalovirus

Country Status (11)

Country Link
US (2) US6893840B2 (de)
EP (1) EP1373524B1 (de)
JP (1) JP4445703B2 (de)
CN (1) CN1247785C (de)
AT (1) ATE323166T1 (de)
AU (1) AU2002211710A1 (de)
CA (1) CA2425852C (de)
DE (1) DE60118798T2 (de)
ES (1) ES2261489T3 (de)
WO (1) WO2002031137A2 (de)
ZA (1) ZA200302667B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0027088D0 (en) * 2000-11-06 2000-12-20 Glaxo Group Ltd DNA expression vectors
JP3630414B2 (ja) 2002-05-21 2005-03-16 インターナショナル・ビジネス・マシーンズ・コーポレーション 塩基配列のクラスタ生成システム、塩基配列のクラスタ生成方法、該クラスタ生成方法を実行するためのプログラム、および該プログラムを記憶したコンピュータ可読な記録媒体、および塩基配列情報提供システム
EP1639109B1 (de) * 2003-06-09 2011-04-13 Corixa Corporation Dna-vektoren
BRPI0415204A (pt) * 2003-10-10 2006-12-05 Powderject Vaccines Inc construção de ácido nucleico, métodos de obtenção da expressão em células de mamìferos de um polipeptìdeo de interesse, e de imunização com ácido nucleico, partìculas revestidas, receptáculo de dosagem para um dispositivo de liberação mediada por partìculas, dispositivo de liberação mediada por partìculas, e, sequência de promotor quimérico isolada purificada
EA010059B1 (ru) * 2003-10-14 2008-06-30 Байоджен Айдек Ма Инк. Flp-опосредованная рекомбинация
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
AU2006237193B2 (en) * 2005-04-22 2012-02-02 Lonza Biologics Plc. Mammalian expression vector comprising the mCMV promoter and first intron of hCMV major immediate early gene
EP2446034A4 (de) * 2009-06-22 2013-11-27 Ipca Lab Ltd Neue polynucleotidmoleküle zur verbesserten genexpression
WO2011027575A1 (ja) * 2009-09-04 2011-03-10 独立行政法人医薬基盤研究所 プロモーターのエンハンサーおよびその利用方法
US20120100573A1 (en) * 2010-10-21 2012-04-26 Thudium Kent B Cytomegalovirus intron a fragments
CN105392885B (zh) 2013-07-19 2020-11-03 赖瑞克斯生物科技公司 用于产生双等位基因敲除的方法和组合物
US11060083B2 (en) 2013-07-19 2021-07-13 Larix Bioscience Llc Methods and compositions for producing double allele knock outs
CN114395559A (zh) * 2014-04-25 2022-04-26 吉尼松公司 高胆红素血症的治疗
US11617788B2 (en) 2018-07-09 2023-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Viral promoters and compositions and methods of use thereof
KR20210080071A (ko) * 2019-12-20 2021-06-30 (주)셀트리온 목적 단백질의 고발현을 위한 인트론을 포함하는 발현 카세트 및 이의 이용
KR20220119703A (ko) 2019-12-24 2022-08-30 아스클레피오스 바이오파마슈티컬, 인크. 조절 핵산 서열
GB202005732D0 (en) 2020-04-20 2020-06-03 Synpromics Ltd Regulatory nucleic acid sequences
EP4176063A2 (de) 2020-07-06 2023-05-10 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Intron-codierte extranukleare transkripte zur proteinübersetzung, rna-codierung und mehrzeitpunktabfrage von nichtcodierender oder proteincodierender rna-regulierung
CN114958914B (zh) * 2022-06-06 2023-09-26 新乡医学院 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939018A (en) * 1984-10-10 1999-08-17 Kawasaki Steel Corporation Martensitic stainless steels for seamless steel pipe
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US5620896A (en) 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US5739018A (en) 1996-08-07 1998-04-14 The Regents Of The University Of California Packaging cell lines for pseudotyped retroviral vectors
US6025338A (en) * 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
WO2000041679A1 (en) 1999-01-13 2000-07-20 Johns Hopkins University School Of Medicine Genetic immunization with co-delivery of nucleic acid and cytokines
CA2378539A1 (en) 1999-07-06 2001-01-11 Merck & Co., Inc. Adenovirus carrying gag gene hiv vaccine

Also Published As

Publication number Publication date
JP4445703B2 (ja) 2010-04-07
US20050191727A1 (en) 2005-09-01
US20050079488A1 (en) 2005-04-14
CA2425852C (en) 2009-09-29
CA2425852A1 (en) 2002-04-18
ES2261489T3 (es) 2006-11-16
US6893840B2 (en) 2005-05-17
US7846687B2 (en) 2010-12-07
CN1247785C (zh) 2006-03-29
DE60118798D1 (de) 2006-05-24
EP1373524B1 (de) 2006-04-12
CN1469930A (zh) 2004-01-21
ZA200302667B (en) 2004-07-05
WO2002031137A3 (en) 2002-10-31
WO2002031137A2 (en) 2002-04-18
AU2002211710A1 (en) 2002-04-22
EP1373524A2 (de) 2004-01-02
JP2004511229A (ja) 2004-04-15
DE60118798T2 (de) 2007-04-12

Similar Documents

Publication Publication Date Title
DE60118798D1 (de) Fragmente der intron a von citomegalovirus
WO1999057325A3 (en) Enzymes mixture
CY1113185T1 (el) Μεθοδοι συνενωσης αποδεκτη πεπτιδιου
WO2003005999A8 (en) Methods of treating cytokine mediated diseases
IL130190A0 (en) Methods and compositions for polypeptide engineering
PL344475A1 (en) Bridged indenopyrrolocarbazoles
AU7381098A (en) Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
AU2002212505A1 (en) Dna expression vectors
DK0981525T3 (da) (2-(2-Thienyl)-ethylamino)-(2-halophenyl)-acetonitriler som mellemprodukter og fremgangsmåde til deres fremstilling
AU2003234198A1 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
MXPA02006167A (es) Promocion de la angiogenesis con survivina.
AU7525398A (en) Inhibitors for urokinase receptor
NO20003146D0 (no) Ketonperoksyd-derivater, deres fremstilling og anvendelse
ATE342998T1 (de) Replikation -defektive baculoviren expressionssystem
WO1995030757A3 (en) Metalloproteases from fusarium and aspergillus having thermolysin-like activity
AU2001252591A1 (en) Novel promoters and gene expression method by using the promoters
AU6832498A (en) Substituted benzyl oximino compounds
AU2003267971A1 (en) Improved alphavirus vectors having attenuated virion structural proteins
DE69632205D1 (de) Herstellung von bacillus thuringiensis integrants
ATE398670T1 (de) Expression von proteolytischen enzymen in koji pilz in gegenwart von einer kohlenstoffquelle
BG102318A (en) Epoxy-azetidinons, their preparation and application
MY127539A (en) Bridged indenopyrrolocarbazoles

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1373524

Country of ref document: EP